Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X
Analysis

Betting big on Gamma Delta T Cells

A novel development platform being developed by a British biotech could lead to new treatments for cancer and auto-inflammatory diseases. Elly Earls finds out why drug giant Takeda is betting big on its potential.

Go Top